Ascendis Pharma A/S (ASND) Q1 2023 Earnings

27AprConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-3.78
-3.01
-2.23
-1.46

Details

Expected EPS
N/A
Actual EPS
-2.13
Surprise EPS
-2.13
Surprise Percent
+∞%

Description

Ascendis Pharma A/S (ASND) has reported earnings of -2.13 per share for Q1 2023.

0 Comments

Share your thoughts